Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company
developing innovative first-in-class drug therapies to treat blinding
diseases of the eye, today announced the U.S. Patent and Trademark
Office (USPTO) granted U.S. Patent Application No. 14/523,243 as U.S.
Patent No. 9,180,047 in a patent titled, "Apparatus and Methods ... read more